CA
NZ
UK
AU
IND
US
Total revenue guidance was revised to USD 1.265 billion to USD 1.295 billion, compared with a previous range of USD 1.24 billion to USD 1.30 billion. NUPLAZID net product sales were narrowed to USD 760 million to USD 775 million from USD 760 million …
The Sandoval matter followed aJuryjudgment that was affirmed in substantial part in April 2026. The company signed a settlement on May 31 with no admission of liability, and the USD 15.0 million payment was made in the third quarter.
Management attributed the 37.8% increase in net sales to a 17.4% increase in pounds shipped and a 21.1% increase in average selling prices. Excluding Midwest, net sales were USD 24.9 million, up 26.3%.
The chairman said the company now has three lines of business: principal investing,Investmentmanagement and insurance, with employees and directors owning over 45% of the common shares. Those lines arrived with new cost items.Mergerand internalization costs were USD 38.28 million, compensation and benefits were USD …
Net premiums earned were USD 242 million, against USD 245 million in both the second quarter of 2026 and the third quarter of 2025. The company said the change was driven mainly by higher ceded premiums from its continued use ofQuotashare reinsurance, partly offset …
On March 2, 2026 the company borrowed USD 125.0 million under its revolvingFacilityand used it to fund an accelerated share repurchase agreement. It received an initial delivery of 6,422,608 shares and a further 4,337,879 shares when the agreement settled on May 7, 2026. Beyond …
The debt actions carried one-time costs. A premium of USD 10 million on the debt repurchase, a USD 3 million write-off of deferred financing costs and USD 2 million of fees on TermLoanB modifications were each excluded from adjusted results. Net financing charges were …
MRD revenue was USD 72.57 million against USD 56.79 million, a 28% increase. Service revenue was USD 72.57 million against USD 50.29 million, and the prior-year quarter also included USD 6.5 million of regulatory milestone revenue. The company tied the increase mainly to USD …
Product revenue was USD 3.50 million against USD 1.70 million a year earlier, and professional service revenue was USD 3.17 million against USD 1.88 million. For nine months, total revenue was USD 19.07 million against USD 12.46 million.
Chairman and chief executive Daniel P. Amos said the company continues to meet customer needs in Japan through products including Anshin Palette medical insurance, Miraito cancer insurance and Tsumitasu savings-type life insurance. In the United States, the stated focus is meeting the needs of …
Please wait processing your request...